Azelastine and olopatadine in the treatment of allergic rhinitis

Kaliner, Michael

doi:10.1016/s1081-1206(10)60355-9

Cited by 31 publications

(9 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Comparisons of INCS to INAH for reduction of nasal symptoms are conflicting, with some showing equality [333][334][335] and some showing superiority of INCS. 336 In a systematic review of INCS and INAH, INAH provide comparable relief of allergic eye symptoms.…”

Section: Intranasal Agents Intranasal Antihistaminesmentioning

confidence: 99%

Rhinitis 2020: A practice parameter update

Parameters

Contributors

2020

Journal of Allergy and Clinical Immunology

167

189

View full text Add to dashboard Cite

Section: Intranasal Agents Intranasal Antihistaminesmentioning

confidence: 99%

Rhinitis 2020: A practice parameter update

Parameters

Contributors

2020

Journal of Allergy and Clinical Immunology

167

189

View full text Add to dashboard Cite

“…Studies that have compared topical antihistamines (azelastine, olopatadine) to INSs (fluticasone) found no superiority of either drug in the treatment of NAR[75, 76]. Of importance, when the topical antihistamines azelastine is used in conjunction with intranasal fluticasone, patients have obtained greater symptomatic relief than with the use of either drug alone [77-79].…”

Section: Treatment Of Rhinitis In the Elderlymentioning

confidence: 99%

Rhinitis in the Elderly

Baptist

Nyenhuis

2016

Immunology and Allergy Clinics of North America

View full text Add to dashboard Cite

By the year 2050, the US aging population will nearly double. As the US aging population grows, it will be increasingly important for healthcare providers to effectively diagnose and manage rhinitis. The nasal symptoms of rhinorrhea, congestion, sneezing, nasal/ocular pruritus, and postnasal drainage affect up to 32% of older adults, and can significantly impact the quality of life. Several underlying factors associated with aging (such as structural changes and immunosenescence) may contribute to the pathogenesis of rhinitis in older adults. Although treatment options for rhinitis exist, special considerations need to be made as comorbidities, limited income, memory loss, and side effects of medications frequently occur in older adults and may impact outcomes.

show abstract

“…20 Studies that have compared topical antihistamines (azelastine, olopatadine) to INSs (fluticasone) have found no superiority of either drug in the treatment of NAR. 22;23 Furthermore, when topical antihistamines and INSs have been used concurrently, patients obtained greater symptomatic relief than with the use of either drug alone. 24–26 Although oral decongestants are effective in treating congestion, few studies have examined the use of oral decongestants for the treatment of NAR.…”

Section: Treatment Of Rhinitismentioning

confidence: 99%

Rhinitis in Older Adults

Nyenhuis

Mathur

2013

Curr Allergy Asthma Rep

View full text Add to dashboard Cite

Rhinitis symptoms of rhinorrhea, congestion, sneezing, nasal/ocular pruritis, and postnasal drainage can significantly affect the quality of life for older adults. As the US population ages, it will be increasingly important for healthcare providers to effectively diagnose and manage rhinitis. Rhinitis is categorized broadly into allergic rhinitis and non-allergic rhinitis. Environmental changes and avoidance measures are a primary means of intervention. In addition, there are several topical therapies (nasal sprays) that can be effective for symptom control.

show abstract

Azelastine and olopatadine in the treatment of allergic rhinitis

Cited by 31 publications

References 39 publications

Rhinitis 2020: A practice parameter update

Rhinitis 2020: A practice parameter update

Rhinitis in the Elderly

Rhinitis in Older Adults

Contact Info

Product

Resources

About